Literature DB >> 9441947

Multidrug transporters from bacteria to man: similarities in structure and function.

H W van Veen1, W N Konings.   

Abstract

Organisms ranging from bacteria to man possess transmembrane transporters which confer resistance to toxic compounds. Underlining their biological significance, prokaryotic and eukaryotic multidrug transport proteins are very similar in structure and function. Therefore, a study of the factors which determine the substrate specificity and energy coupling to drug translocation in 'simple' microorganisms has significance for multidrug resistance of mammalian cells. This chapter represents a comprehensive review in which we will summarize the current state of knowledge on three major aspects of drug efflux-based multidrug resistance: (i) the functional and structural similarities among secondary and ABC-type drug transporters encountered in prokaryotic and eukaryotic cells; (ii) the molecular mechanism of these transporters; and (iii) their potential physiological role.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9441947     DOI: 10.1006/scbi.1997.0064

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  22 in total

1.  The homodimeric ATP-binding cassette transporter LmrA mediates multidrug transport by an alternating two-site (two-cylinder engine) mechanism.

Authors:  H W van Veen; A Margolles; M Müller; C F Higgins; W N Konings
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

Review 2.  Molecular properties of bacterial multidrug transporters.

Authors:  M Putman; H W van Veen; W N Konings
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

3.  Expression and purification of the first nucleotide-binding domain and linker region of human multidrug resistance gene product: comparison of fusions to glutathione S-transferase, thioredoxin and maltose-binding protein.

Authors:  C Wang; A F Castro; D M Wilkes; G A Altenberg
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

4.  In vitro folding and assembly of the Escherichia coli ATP-binding cassette transporter, BtuCD.

Authors:  Natalie D Di Bartolo; Rikki N Hvorup; Kaspar P Locher; Paula J Booth
Journal:  J Biol Chem       Date:  2011-02-23       Impact factor: 5.157

5.  Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers.

Authors:  D W Miller; E V Batrakova; A V Kabanov
Journal:  Pharm Res       Date:  1999-03       Impact factor: 4.200

Review 6.  Energy metabolism and drug efflux in Mycobacterium tuberculosis.

Authors:  Philippa A Black; Robin M Warren; Gail E Louw; Paul D van Helden; Thomas C Victor; Bavesh D Kana
Journal:  Antimicrob Agents Chemother       Date:  2014-03-10       Impact factor: 5.191

7.  Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred.

Authors:  A T Remaley; S Rust; M Rosier; C Knapper; L Naudin; C Broccardo; K M Peterson; C Koch; I Arnould; C Prades; N Duverger; H Funke; G Assman; M Dinger; M Dean; G Chimini; S Santamarina-Fojo; D S Fredrickson; P Denefle; H B Brewer
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

8.  Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells.

Authors:  E Batrakova; S Lee; S Li; A Venne; V Alakhov; A Kabanov
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

9.  Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers.

Authors:  E V Batrakova; S Li; D W Miller; A V Kabanov
Journal:  Pharm Res       Date:  1999-09       Impact factor: 4.200

Review 10.  An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers.

Authors:  Alexander V Kabanov; Elena V Batrakova; Valery Yu Alakhov
Journal:  J Control Release       Date:  2003-08-28       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.